Publication | Closed Access

Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer

Breast OncologyMedicinePharmacologyBreast CancerCancer TreatmentOncologyRadiation OncologyMolecular OncologyFinal Results